Filing Details

Accession Number:
0001209191-17-060967
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-15 17:43:10
Reporting Period:
2017-11-13
Accepted Time:
2017-11-15 17:43:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1581950 Jr. Clayton Lewis Cantley C/O Agios Pharmaceuticals, Inc.
88 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-13 1,000 $62.07 82,394 No 4 S Direct
Common Stock Disposition 2017-11-13 1,000 $62.07 82,434 No 4 S Indirect See footnote
Common Stock Disposition 2017-11-14 691 $59.36 81,703 No 4 S Direct
Common Stock Disposition 2017-11-14 691 $59.36 81,743 No 4 S Indirect See footnote
Common Stock Disposition 2017-11-14 309 $60.46 81,394 No 4 S Direct
Common Stock Disposition 2017-11-14 309 $60.46 81,434 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Direct
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,803 Indirect See footnote
Common Stock 20,803 Indirect See footnote
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Shares held by Vicki Lee Sato, who is the reporting person's spouse.
  4. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
  7. Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.